A Study of Trastuzumab Emtansine Versus Capecitabine + Lapatinib in Participants With HER2-positive Locally Advanced or Metastatic Breast Cancer
Clinical trial NCT00829166 · COMPLETED
Trial details
- NCT number
- NCT00829166
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-02-01
- Primary completion
- 2012-07-01
- Enrollment
- 991
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.